Latest News

Formerly called the Conclave Awards, the 2025 Spring Yale Cancer Center awards honored research, clinical expertise, and support staff at the Hotel Marcel, New Haven on April 1, 2025.

Dr. Roy S. Herbst, MD, PhD received the 2024 Ezra Greenspan Award from The Chemotherapy+ Foundation at a gala in New York Nov. 19, 2024. He is a deputy director of the Yale Cancer Center and Chief of Hematology/Medical Oncology, YCC and Smilow Cancer Hospital; Assistant Dean for Translational Research, Yale School of Medicine; Program Director, Master of Health Science—Clinical Investigation Track (MHS-CI)

On November 13, 2024, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital presented a patient forum: "Understanding Lung Cancer: A Conference to Raise Awareness and Offer Hope to Those Impacted by Lung Cancer."

Dr. Katerina Politi on Yale Cancer Answers.

A member of the Yale School of Medicine faculty since 2010, Politi co-leads the Cancer Signaling Networks Research Program at the Yale Cancer Center.

The workshop, hosted by Yale Cancer Center and Smilow Cancer Hospital June 12 – 13, was held in commemoration of the 20th anniversary of the discovery of EGFR mutation in lung cancer, which launched the era of personalized medicine in advanced non-small cell lung cancer, leading to a dramatic shift in treatment.

May 2024 marked the 20th anniversary of the publication of papers on the role of EGFR mutation in lung cancer. This is a seminal event that changed the history of this disease and that can be traced back to one reason why cancer mortality has been declining in the United States.

On June 12 – 13, 2024, Yale Cancer Center and Smilow Cancer Hospital hosted the annual Lung Cancer SPORE Workshop at Yale West Campus. This year’s two-day workshop was held in commemoration of the 20th anniversary of the discovery of the epidermal growth factor receptor (EGFR) mutation in lung cancer, which launched the era of personalized medicine in advanced non-small cell lung cancer (NSCLC), leading to a dramatic shift in treatment.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.